Literature DB >> 10590249

A single Na(+) channel mutation causing both long-QT and Brugada syndromes.

C Bezzina1, M W Veldkamp, M P van Den Berg, A V Postma, M B Rook, J W Viersma, I M van Langen, G Tan-Sindhunata, M T Bink-Boelkens, A H van Der Hout, M M Mannens, A A Wilde.   

Abstract

Mutations in SCN5A, the gene encoding the cardiac Na(+) channel, have been identified in 2 distinct diseases associated with sudden death: one form of the long-QT syndrome (LQT(3)) and the Brugada syndrome. We have screened SCN5A in a large 8-generation kindred characterized by a high incidence of nocturnal sudden death, and QT-interval prolongation and the "Brugada ECG" occurring in the same subjects. An insertion of 3 nucleotides (TGA) at position 5537, predicted to cause an insertion of aspartic acid (1795insD) in the C-terminal domain of the protein, was linked to the phenotype and was identified in all electrocardiographically affected family members. ECGs were obtained from 79 adults with a defined genetic status (carriers, n=43; noncarriers, n=36). In affected individuals, PR and QRS durations and QT intervals are prolonged (P<0.0001 for all parameters). ST segment elevation in the right precordial leads is present as well (P<0.0001). Twenty-five family members died suddenly, 16 of them during the night. Expression of wild-type and mutant Na(+) channels in Xenopus oocytes revealed that the 1795insD mutation gives rise to a 7.3-mV negative shift of the steady-state inactivation curve and an 8.1-mV positive shift of the steady-state activation curve. The functional consequence of both shifts is likely to be a reduced Na(+) current during the upstroke of the action potential. LQT(3) and Brugada syndrome are allelic disorders but may also share a common genotype.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10590249     DOI: 10.1161/01.res.85.12.1206

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  177 in total

1.  Na(+) channel mutation that causes both Brugada and long-QT syndrome phenotypes: a simulation study of mechanism.

Authors:  Colleen E Clancy; Yoram Rudy
Journal:  Circulation       Date:  2002-03-12       Impact factor: 29.690

Review 2.  Defective cardiac ion channels: from mutations to clinical syndromes.

Authors:  Colleen E Clancy; Robert S Kass
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

3.  Structural effects of an LQT-3 mutation on heart Na+ channel gating.

Authors:  M Tateyama; H Liu; A-S Yang; J W Cormier; R S Kass
Journal:  Biophys J       Date:  2004-03       Impact factor: 4.033

Review 4.  Electrophysiological patterning of the heart.

Authors:  Bastiaan J Boukens; Vincent M Christoffels
Journal:  Pediatr Cardiol       Date:  2012-02-25       Impact factor: 1.655

Review 5.  Inherited calcium channelopathies in the pathophysiology of arrhythmias.

Authors:  Luigi Venetucci; Marco Denegri; Carlo Napolitano; Silvia G Priori
Journal:  Nat Rev Cardiol       Date:  2012-06-26       Impact factor: 32.419

Review 6.  Genetics of sudden cardiac death caused by ventricular arrhythmias.

Authors:  Roos F Marsman; Hanno L Tan; Connie R Bezzina
Journal:  Nat Rev Cardiol       Date:  2013-12-10       Impact factor: 32.419

Review 7.  Brugada syndrome: current clinical aspects and risk stratification.

Authors:  Takanori Ikeda
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-07       Impact factor: 1.468

Review 8.  Ventricular tachycardia in structurally normal hearts.

Authors:  T Scott Wall; Roger A Freedman
Journal:  Curr Cardiol Rep       Date:  2002-09       Impact factor: 2.931

9.  SCN5A (NaV1.5) Variant Functional Perturbation and Clinical Presentation: Variants of a Certain Significance.

Authors:  Brett M Kroncke; Andrew M Glazer; Derek K Smith; Jeffrey D Blume; Dan M Roden
Journal:  Circ Genom Precis Med       Date:  2018-05

Review 10.  Sudden cardiac death without structural heart disease: update on the long QT and Brugada syndromes.

Authors:  Ilan Goldenberg; Arthur J Moss; Wojciech Zareba
Journal:  Curr Cardiol Rep       Date:  2005-09       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.